| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.84B | 20.39B | 20.83B | 23.51B | 21.11B | 18.71B |
| Gross Profit | 6.09B | 5.91B | 7.82B | 2.35B | 6.09B | 4.89B |
| EBITDA | 2.10B | 2.30B | 2.47B | 1.60B | 1.65B | 1.74B |
| Net Income | 869.80M | 1.01B | 1.15B | 601.60M | 662.43M | 647.56M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 23.11B | 21.99B | 19.51B | 17.79B | 16.81B |
| Cash, Cash Equivalents and Short-Term Investments | 762.91M | 996.90M | 554.16M | 3.22B | 318.73M | 803.60M |
| Total Debt | 0.00 | 5.34B | 5.29B | 5.10B | 5.66B | 5.08B |
| Total Liabilities | -8.99B | 14.12B | 13.84B | 12.34B | 11.07B | 10.64B |
| Stockholders Equity | 8.99B | 8.99B | 8.15B | 7.17B | 6.72B | 6.17B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 432.10M | 409.06M | 1.16B | -757.58M | 1.68B |
| Operating Cash Flow | 0.00 | 1.22B | 766.36M | 1.69B | 590.26M | 2.25B |
| Investing Cash Flow | 0.00 | -933.52M | -432.53M | -678.80M | -711.52M | -983.93M |
| Financing Cash Flow | 0.00 | -133.82M | -223.99M | -1.01B | 4.98M | -1.50B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | ₹6.40B | 7.00 | ― | 1.19% | -3.72% | -50.02% | |
68 Neutral | ₹22.97B | 7.01 | ― | 2.00% | 17.71% | 18.17% | |
66 Neutral | ₹45.14B | 37.03 | ― | 0.35% | -7.81% | -6.64% | |
63 Neutral | ₹86.53B | 21.36 | ― | 0.79% | 9.74% | -6.32% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
54 Neutral | ₹78.20B | 29.91 | ― | 0.63% | 14.75% | -15.81% | |
46 Neutral | ₹53.68B | -7.22 | ― | ― | -18.81% | -57.61% |
DCM Shriram Industries Limited has informed shareholders and the stock exchanges that, under its ongoing composite scheme of arrangement, the record date for determining eligibility for share allotment in its resultant companies DCM Shriram Fine Chemicals Limited and DCM Shriram International Limited has been revised from 19 December 2025 to 26 December 2025, due to pending formalities related to extinguishment and allotment of shares of a transferor company. Eligible shareholders on the new record date will receive one fully paid equity share of face value ₹2 each in both DCM Shriram Fine Chemicals and DCM Shriram International for every one fully paid equity share of ₹2 held in DCM Shriram Industries, though these new shares will remain non-tradable until listing and trading permissions are granted by BSE and NSE, a process expected to take about 45–60 days after the requisite applications are filed, temporarily affecting liquidity but clarifying the timeline and terms for stakeholders awaiting the scheme’s implementation.
DCM Shriram Industries Limited has announced that the National Company Law Tribunal (NCLT), New Delhi Bench, has sanctioned a Composite Scheme of Arrangement involving Lily Commercial Private Limited, DCM Shriram Industries Limited, DCM Shriram Fine Chemicals Limited, and DCM Shriram International Limited. This scheme, which involves the transfer and restructuring of assets among these entities, will become effective upon filing with the Registrar of Companies. This development is significant for the company’s operational restructuring and could have implications for its market positioning and stakeholder interests.